메뉴 건너뛰기




Volumn 40, Issue 8, 2010, Pages 669-677

Structural changes in exon 11 of MEF2A are not related to sporadic coronary artery disease in Han Chinese population

Author keywords

Coronary artery disease; MEF2A; subcellular localization; transcriptional activation; trinucleotide (CAG) repeat

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2A; UNCLASSIFIED DRUG;

EID: 77954480449     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02307.x     Document Type: Article
Times cited : (13)

References (26)
  • 1
    • 34147181118 scopus 로고    scopus 로고
    • Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease
    • Luo AK, Jefferson BK, Garcia MJ, Ginsburg GS, Topol EJ. Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease. J Med Genet 2007 44 : 161 165.
    • (2007) J Med Genet , vol.44 , pp. 161-165
    • Luo, A.K.1    Jefferson, B.K.2    Garcia, M.J.3    Ginsburg, G.S.4    Topol, E.J.5
  • 2
    • 33750445938 scopus 로고    scopus 로고
    • Genetic approaches to coronary heart disease
    • Cohen JC. Genetic approaches to coronary heart disease. J Am Coll Cardiol 2006 48 : 10 4.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 10-4
    • Cohen, J.C.1
  • 3
    • 33749018788 scopus 로고    scopus 로고
    • Genetic susceptibility to myocardial infarction and coronary artery disease
    • Topol EJ, Smith J, Plow EF, Wang Q. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 2006 15 : R117 23.
    • (2006) Hum Mol Genet , vol.15 , pp. 117-23
    • Topol, E.J.1    Smith, J.2    Plow, E.F.3    Wang, Q.4
  • 4
    • 33644840046 scopus 로고    scopus 로고
    • Genetic susceptibility to coronary artery disease: From promise to progress
    • Watkins H, Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet 2006 7 : 163 173.
    • (2006) Nat Rev Genet , vol.7 , pp. 163-173
    • Watkins, H.1    Farrall, M.2
  • 5
    • 20444424537 scopus 로고    scopus 로고
    • Advances in the genetic basis of coronary artery disease
    • Wang Q. Advances in the genetic basis of coronary artery disease. Curr Atheroscler Rep 2005 7 : 235 241. (Pubitemid 40796757)
    • (2005) Current Atherosclerosis Reports , vol.7 , Issue.3 , pp. 235-241
    • Wang, Q.1
  • 6
    • 0032437107 scopus 로고    scopus 로고
    • Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins
    • Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 1998 14 : 167 196.
    • (1998) Annu Rev Cell Dev Biol , vol.14 , pp. 167-196
    • Black, B.L.1    Olson, E.N.2
  • 7
    • 0036165434 scopus 로고    scopus 로고
    • MEF2: A calcium-dependent regulator of cell division differentiation and death
    • McKinsey TA, Zhang ChL, Olson EN. MEF2: a calcium-dependent regulator of cell division differentiation and death. Trends Biochem Sci 2002 27 : 40 7.
    • (2002) Trends Biochem Sci , vol.27 , pp. 40-7
    • McKinsey, T.A.1    Zhang, C.L.2    Olson, E.N.3
  • 8
    • 0344827206 scopus 로고    scopus 로고
    • Mutation of MEF2A in an inherited disorder with features of coronary artery disease
    • Wang LJ, Fan Ch, Topol SE, Topol EJ, Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003 302 : 1578 1581.
    • (2003) Science , vol.302 , pp. 1578-1581
    • Wang, L.J.1    Fan, C.2    Topol, S.E.3    Topol, E.J.4    Wang, Q.5
  • 11
    • 16844382494 scopus 로고    scopus 로고
    • MEF2A sequence variants and coronary artery disease: A change of heart?
    • Altshuler D, Hirschhorn JN. MEF2A sequence variants and coronary artery disease: a change of heart? J Clin Invest 2005 115 : 831 833.
    • (2005) J Clin Invest , vol.115 , pp. 831-833
    • Altshuler, D.1    Hirschhorn, J.N.2
  • 12
    • 25644443908 scopus 로고    scopus 로고
    • Assessment of MEF2A mutations in myocardial infarction in Japanese patients
    • Kajimoto K, Shioji K, Tago N, Tomoike H, Nonogi H, Goto Y et al. Assessment of MEF2A mutations in myocardial infarction in Japanese patients. Circ J 2005 69 : 1192 1195.
    • (2005) Circ J , vol.69 , pp. 1192-1195
    • Kajimoto, K.1    Shioji, K.2    Tago, N.3    Tomoike, H.4    Nonogi, H.5    Goto, Y.6
  • 13
    • 33747684091 scopus 로고    scopus 로고
    • Lack of MEF2A Delta7aa mutation in Irish families with early onset ischaemic heart disease, a family based study
    • Horan PG, Allen AR, Hughes AE, Patterson CC, Spence M, McGlinchey PG et al. Lack of MEF2A Delta7aa mutation in Irish families with early onset ischaemic heart disease, a family based study. BMC Med Genet 2006 7 : 65.
    • (2006) BMC Med Genet , vol.7 , pp. 65
    • Horan, P.G.1    Allen, A.R.2    Hughes, A.E.3    Patterson, C.C.4    Spence, M.5    McGlinchey, P.G.6
  • 14
    • 51849093638 scopus 로고    scopus 로고
    • MEF2A sequence variants in Turkish population
    • Gulec S, Akar AR, Akar N. MEF2A sequence variants in Turkish population. Clin Appl Thromb Hemost 2008 14 : 465 467.
    • (2008) Clin Appl Thromb Hemost , vol.14 , pp. 465-467
    • Gulec, S.1    Akar, A.R.2    Akar, N.3
  • 15
    • 38049144096 scopus 로고    scopus 로고
    • Lack of association between the MEF2A gene and myocardial infarction
    • Lieb W, Mayer B, König IR, Borwitzky I, Götz A, Kain S et al. Lack of association between the MEF2A gene and myocardial infarction. Circulation 2008 117 : 185 191.
    • (2008) Circulation , vol.117 , pp. 185-191
    • Lieb, W.1    Mayer, B.2    König, I.R.3    Borwitzky, I.4    Götz, A.5    Kain, S.6
  • 16
    • 32944473313 scopus 로고    scopus 로고
    • The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction
    • Hsu LA, Chang CJ, Teng MS, Wu S, Hu CF, Chang WY et al. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J Med Genet 2006 43 : 167 169.
    • (2006) J Med Genet , vol.43 , pp. 167-169
    • Hsu, L.A.1    Chang, C.J.2    Teng, M.S.3    Wu, S.4    Hu, C.F.5    Chang, W.Y.6
  • 17
    • 34548750419 scopus 로고    scopus 로고
    • Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population
    • DOI 10.1515/CCLM.2007.159
    • Han Y, Yang Y, Zhang X, Yan C, Xi S, Kang J. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population. Clin Chem Lab Med 2007 45 : 987 992. (Pubitemid 47424849)
    • (2007) Clinical Chemistry and Laboratory Medicine , vol.45 , Issue.8 , pp. 987-992
    • Han, Y.1    Yang, Y.2    Zhang, X.3    Yan, C.4    Xi, S.5    Kang, J.6
  • 19
    • 0034094873 scopus 로고    scopus 로고
    • Glutamine repeats and neurodegeneration
    • Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000 23 : 217 247.
    • (2000) Annu Rev Neurosci , vol.23 , pp. 217-247
    • Zoghbi, H.Y.1    Orr, H.T.2
  • 20
    • 1942453894 scopus 로고    scopus 로고
    • HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo
    • Anderson JP, Dodou E, Heidt AB, De Val SJ, Jaehnig EJ, Greene SB et al. HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo. Mol Cell Biol 2004 24 : 3757 3768.
    • (2004) Mol Cell Biol , vol.24 , pp. 3757-3768
    • Anderson, J.P.1    Dodou, E.2    Heidt, A.B.3    De Val, S.J.4    Jaehnig, E.J.5    Greene, S.B.6
  • 21
    • 37349030391 scopus 로고    scopus 로고
    • The androgen receptor and prostate cancer: A role for sexual selection and sexual conflict?
    • Summers K, Crespi B. The androgen receptor and prostate cancer: a role for sexual selection and sexual conflict? Med Hypotheses 2008 70 : 435 443.
    • (2008) Med Hypotheses , vol.70 , pp. 435-443
    • Summers, K.1    Crespi, B.2
  • 23
    • 37849030901 scopus 로고    scopus 로고
    • Polyglutamine diseases: Emerging concepts in pathogenesis and therapy
    • Shao J, Diamond MI. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum Mol Genet 2007 16 : R115 23.
    • (2007) Hum Mol Genet , vol.16 , pp. 115-23
    • Shao, J.1    Diamond, M.I.2
  • 24
    • 33747359908 scopus 로고    scopus 로고
    • Polyglutamine neurodegenerative diseases and regulation of transcription: Assembling the puzzle
    • Riley BE, Orr HT. Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. Genes Dev 2006 20 : 2183 2192.
    • (2006) Genes Dev , vol.20 , pp. 2183-2192
    • Riley, B.E.1    Orr, H.T.2
  • 25
    • 33746117919 scopus 로고    scopus 로고
    • Polyglutamine disease: Recent advances in the neuropathology of dentatorubral pallidoluysian atrophy
    • Yamada M, Shimohata M, Sato T, Tsuji S, Takahashi H. Polyglutamine disease: recent advances in the neuropathology of dentatorubral pallidoluysian atrophy. Neuropathology 2006 26 : 346 351.
    • (2006) Neuropathology , vol.26 , pp. 346-351
    • Yamada, M.1    Shimohata, M.2    Sato, T.3    Tsuji, S.4    Takahashi, H.5
  • 26
    • 33751020835 scopus 로고    scopus 로고
    • Myocyte enhancing factor-2A in Alzheimer's disease: Genetic analysis and association with MEF2A-polymorphisms
    • González P, Álvarez V, Menéndez M, Lahoz CH, Martínez C, Corao AI et al. Myocyte enhancing factor-2A in Alzheimer's disease: genetic analysis and association with MEF2A-polymorphisms. Neurosci Lett 2007 411 : 47 51.
    • (2007) Neurosci Lett , vol.411 , pp. 47-51
    • González, P.1    Álvarez, V.2    Menéndez, M.3    Lahoz, C.H.4    Martínez, C.5    Corao, A.I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.